Clinical Trial Update: Study of Mirtazapine for Agitation in Dementia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial studying mirtazapine for agitation in dementia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia

Drugs mentioned

• mirtazapine (mirtazapine)

Snippet

Sponsor: University of Sussex | Conditions: Dementia | Phase 3 | Status: COMPLETED